Analysis of Circulating Immune Complexes and Detection of Microbial Antigenic Components in Breast Tumours in Anambra State Nigeria
Cancer Research Journal
Volume 5, Issue 1, January 2017, Pages: 1-8
Received: Dec. 13, 2016; Accepted: Dec. 27, 2016; Published: Jan. 25, 2017
Views 2962      Downloads 113
Authors
Michael Chukwudi Ezeani, Department of Immunology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria
Charles Chinedum Onyenekwe, Department of Medical Laboratory Science, Faculty of Health Science and Technology, Nnamdi Azikiwe University, Awka, Nigeria
Samual Chukwuemeka Meludu, Department of Human Biochemistry, Faculty of Basic Medical Sciences, Nnamdi Azikiwe University, Awka, Nigeria
Gabriel Udeze Chianakwana, Department of Surgery, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria
Daniel Chukwuemeka Anyiam, Histopathology Department, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria
Comfort Nne Akujobi, Department of Medical Microbiology/Parasitology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria
Chiemelu Dickson Emegoakor, Department of Surgery, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria
Martin Ositadimma Ifeanyichukwu, Department of Medical Laboratory Science, Faculty of Health Science and Technology, Nnamdi Azikiwe University, Awka, Nigeria
Ujuamala Uloma Ezeani, Medical Centre, Pharmaceutical Unit, Nnamdi Azikiwe University, Nnewi Campus, Nigeria
Nnadozi Okwudili Josiah, Department of Chemical Pathology, Medical Laboratory Section, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria
Obi Ejeatuluchkwu, Pharmacology Department, Faculty of Medicine, Nnamdi Azikiwe University Awka, Nigeria
Jonathan Madukwe, Histopathology Department, National Hospital, Abuja, Nigeria
Article Tools
Follow on us
Abstract
Quantitative measurement of circulating immune complexes in cancer patients is a widely accepted measure linking immune complexes as useful for treatment monitoring. However, the components of these immune complexes are generally understudied. By the analysis of immune complexes, this work elicited some microbial agents that could be associated with breast tumours. Total of 99 female subjects were randomly recruited for this study, of which 24 had benign tumour, 25 had malignant tumour and 50 were tumour free controls subjects. The mean age of the female subjects with benign breast tumour was 37.9±10.1 years; malignant 49.6±10.8 and control subjects 35.9±9.0, and they were confirmed free from chemotherapy, autoimmune diseases and HIV infection. Immune complexes were precipitated and dissociated. Characterization of the antigens/antibodies was done using Enzyme linked immunoassay technique. Microbial antigenic components were detected in 21 benign tumour subjects, 20 malignant tumour subjects and 11 control subjects. Homogeneity and heterogeneity patterns of microbial antigenic distribution were seen in different groups. Heterogeneity pattern was prevalent in subjects with tumours. Detection of HCV was significantly high in subjects with benign and malignant tumours, while presence of Plasmodium falciparum, Helicobacter pylori and Salmonella typhi was also prominent. HBV and treponema pallidum were implicated. Heterogeneity pattern was prevalent in late stages of breast cancer while Plasmodium falciparum, HCV and Salmonella typhi were most prominent. The burden of microbial infection is prevalent in breast tumour subjects. Presence of the microbial antigens would represent the burden of the microbial infection in tumour development and the consequences of the persistent circulation of these microbial proteins were discussed.
Keywords
Circulating Immune Complexes, Breast Tumourigenesis, Microbial Agents, Antigenic Components
To cite this article
Michael Chukwudi Ezeani, Charles Chinedum Onyenekwe, Samual Chukwuemeka Meludu, Gabriel Udeze Chianakwana, Daniel Chukwuemeka Anyiam, Comfort Nne Akujobi, Chiemelu Dickson Emegoakor, Martin Ositadimma Ifeanyichukwu, Ujuamala Uloma Ezeani, Nnadozi Okwudili Josiah, Obi Ejeatuluchkwu, Jonathan Madukwe, Analysis of Circulating Immune Complexes and Detection of Microbial Antigenic Components in Breast Tumours in Anambra State Nigeria, Cancer Research Journal. Vol. 5, No. 1, 2017, pp. 1-8. doi: 10.11648/j.crj.20170501.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Prathap Kumar S. Mahalingaiah and Kamaleshwar P. Singh. Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells. PLoS One. 2014; 9 (1): e87371.
[2]
Xuan C, Jaime MS, Alice C. Microbial Dysbiosis Is Associated with Human Breast Cancer 2014; v PLoS One. 9, e83744.
[3]
Elima Jedy-Agba, Maria Paula Curado, Olufemi Ogunbiyi et al. Cancer Epidemiology. 2012; 36 (5): e271–e278.
[4]
Rathore K, Choudhary S, Odoi A, et al. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 2012; 33: 174–183
[5]
Anand P, Kunnumakkara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research 2008; 25: 2097–2116.
[6]
Abhishek DG, Lorenzo G, Lionel A, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontier Immunology 2015; doi.org/10.3389/fimmu.2015.00588
[7]
Nash JT, Taylor PR, Botto M et al. Immune complex processing in C1q-deficient mice. Clinical Experimental Immunology 2001; 123 (2): 196–202.
[8]
Brunner M, and Sigal LH. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. Journal Clinical Microbiology 2001; 39: 3213-3221.
[9]
Bonnet M. Buc E, Sauvanet P et al. Colonization of the human gut by E. Coli and colorectal cancer risk. Clinical Cancer Research 2014; 20: 859–867.
[10]
Khan AA, Shrivastava A, Khurshid M, et al. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochimistry Biophysics Acta 2012; 1826: 331–337.
[11]
Reinwald M, Boch T, Hofmann W, et al., Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors. Biomarker Insights 2015; 10 (Suppl 3): 55–68.
[12]
Zembower TR. Epidemiology of Infections in Cancer Patients. Cancer treatment and research 2014; 161: 43-89
[13]
MC Ezeani, MI Agba CC Onyenekwe, I Anahalu, CC Azikiwe, BE Unaezef, UU Ezeani Aerobacteriology of laboratories and offices: Evidence of high risk exposure to immune complex formation in Nigeria. Asian Pacific Journal of Tropical Disease 2011; 1 (2): 131-136.
[14]
Parveen S, Neeraj T, Renuka JB, Deka AC. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients - A follow up study. Indian journal of dental research 2010; 21 (1): 10-125
[15]
Rai S and Mody RN. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy 2012; 8 (6): 116-122
[16]
Stosor V. and Zembower TR. Infectious Complications in Cancer Patients. Cancer Treatment and Research 161, DOI: 10.1007/978-3-319-04220-6_2,
[17]
Donnelly JP, Blijlevens NMA, De Pauw BE. Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, 2009; 3781–3792
[18]
Blaser MJ, Kirschner. The equilibria that permit bacterial persistence in human hosts. Nature 2007; 449: 843–9.
[19]
Balkwill F, Mantovani A, et al. “Inflammation and cancer: back to Virchow?” The Lancet 2001; 357: 539–545
[20]
Johny E Elkahwaji The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Research Reproduction Urology 2013; 5: 1–10.
[21]
Dawit Kidane, Wook Jin Chae, Jennifer Czochor, Kristin A. Eckert, Peter M. Glazer, Alfred L. M. Bothwell, and Joann B. SweasyInterplay between DNA repair and inflammation, and the link to cancer. Critical Review Biochemistry Molecular Biology 2014; 49 (2): 116–139.
[22]
Chinnusamy V, Zhu JK. RNA-directed DNA methylation and demethylation in plants. Science in China. Series C, Life Science 2009; 52: 331–343.
[23]
Gilbert SF, McDonald E, Boyle N, Buttino N, Gyi L, Mai M. Symbiosis as a source of selectable epigenetic variation: taking the heat for the big guy. Philosophical Transaction Royal Society 2010; 365: 671–678.
[24]
Tanya N. Mayadas, George C. Tsokos and Naotake Tsuboi, Mechanisms of Immune Complex Mediated Neutrophil Recruitment and Tissue Injury. Circulation 2009; 120 (20): 2012–2024
[25]
Schetter AJ, Heegaard NH, Harris CC, et al. Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31: 37–49.
[26]
Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infectious Disease 2005; 11 (9): 558–567.
[27]
Su F-H, Shih-Ni C, Pei-Chun C, Fung-Chang S, Chien-Tien S, Chih-Ching Y. (2011). Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study Bio Medical Center Cancer11: 495.
[28]
American Cancer Society (2015). Cancer Facts and Figures. Atlanta, Ga 2015
[29]
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FG, Trotti A. AJCC Cancer Staging Manual 7. New York: Springer; 2010.
[30]
Blaser MJ, Understanding Microbe-Induced Cancers. Cancer Preview Research 2008; 1: 15
[31]
Blaser MJ, Kirschner D The equilibria that permit bacterial persistence in human hosts. Nature 2007; 449: 843–9
[32]
Blaser MJ, Nomura A, Lee J, Stemmerman GN, Perez-Perez GI. Early life family structure and microbially-induced cancer risk. PLoS Med 2007; 4: 53–58.
[33]
Chang YJ, Wu MS, Lin JT, Pestell RG, Blaser MJ, Chen CC. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell Microbiology 2006 8: 1740–52.
[34]
Paschos K, Allday MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends in Microbiology 2010; 18: 439–447.
[35]
Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nature Review Microbiology 2005; 3: 281–294.
[36]
Bierne H, Mélanie H, Pascale C. (2012). Epigenetics and Bacterial Infections. Cold Spring Harb Perspective Medicine 2012; 2: a010272.
[37]
Ribet D, Cossart P. (2010). SUMOylation and bacterial pathogens. Virulence 6: 532–534.
[38]
Perrett CA, Lin DY, Zhou D. Interactions of bacterial proteins with host eukaryotic ubiquitin pathways. Frontier Microbiology 2011; 2: 143.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186